Discovery Inc. Series B (DISCB) Peer Comparison
$24.45
$0.00 (0.00%)As on 14-Apr-2022 09:30EDT
Market cap
$12,420 Mln
Revenue (TTM)
$12,558 Mln
P/E Ratio
17.7
P/B Ratio
1.1
Div. Yield
0 %
Edit
| Discovery Inc. Series B (DISCB) | AstraZeneca - ADR | Grupo Televisa S.A. - ADR | Liberty Media Corp Braves C (BATRK) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | Nexstar Media Group Inc. Class A (NXST) | Paramount Skydance Corp Class B | Sinclair Broadcast Group Inc. Class A (SBGI) | Warner Music Group Corp. Class A (WMG) | |
|---|---|---|---|---|---|---|---|---|---|
Market cap ($ Mln) |
12,420 | 257,416 | 1,434 | 3,332 | 9,780 | 5,735 | 11,612 | 1,040 | 14,192 |
Revenue ($ Mln) |
12,558 | 61,366 | 57,743 | 750 | 1,154 | 6,963 | 29,432 | 3,256 | 7,304 |
Net Profit ($ Mln) |
1,322.00 | 10,446.00 | -8,956.01 | -64.19 | 7.76 | 188.00 | -621.00 | 52.00 | 672.00 |
Net Margin (%) |
10.15 | 17.02 | -15.51 | -8.56 | 0.67 | 2.70 | -2.11 | 1.60 | 9.20 |
RoE (%) |
27.04 | 21.11 | -9.71 | -12.40 | -2.85 | 9.61 | -5.35 | 10.45 | 86.28 |
Price to Earnings |
17.74 | 24.63 | -- | -- | 1,269.25 | 35.25 | 345.00 | 18.24 | 21.70 |
Price-To-Book |
1.07 | 5.07 | 0.24 | 6.61 | 1.57 | 2.53 | 0.98 | 2.74 | 16.60 |
Income Statement ($ Mln)
| Discovery Inc. Series B (DISCB) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
12,558.00 | 73,915.43 | 37,417.00 | 28,586.00 | 563.72 |
|
Cost of Revenue
|
4,887.00 | 46,653.60 | 12,437.00 | 18,134.00 | 376.35 |
|
Gross Profit
|
7,571.00 | 27,261.83 | 24,980.00 | 10,452.00 | 187.37 |
|
Operating Expenses
|
5,226.00 | 21,089.04 | 23,924.00 | 6,398.00 | 168.13 |
|
Operating Profit (EBIT)
|
1,969.00 | 6,172.80 | 1,056.00 | 4,054.00 | 19.24 |
|
Other Income
|
466.00 | -- | -- | -- | -546.00 |
|
Profit before Tax
|
1,812.00 | 2,441.94 | -265.00 | 5,115.00 | -3.31 |
|
Provision for Tax
|
331.00 | 1,673.05 | -380.00 | 646.00 | 9.69 |
|
Profit after Tax (Net Income)
|
1,322.00 | 6,055.83 | 112.00 | 4,543.00 | -13.01 |
|
Minority Interest
|
1,883.00 | -- | -- | -- | 3,590.00 |
|
Consolidated Profit
|
1,250.00 | 5,386.50 | -- | -- | 796.00 |
Liabilities ($ Mln)
| Discovery Inc. Series B (DISCB) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
11,969.00 | 95,786.76 | 39,268.00 | 22,970.00 | 296.00 |
|
Minority Interest
|
1,883.00 | -- | -- | -- | 3,590.00 |
|
Non-Current Liabilities
|
16,675.00 | 140,615.17 | 43,482.00 | 26,171.00 | 1,204.00 |
|
Current Liabilities
|
3,562.00 | 56,498.58 | 22,594.00 | 9,479.00 | 136.00 |
|
Total Liabilities
|
34,427.00 | 292,900.51 | 105,363.00 | 58,620.00 | 1,636.00 |
Assets ($ Mln)
| Discovery Inc. Series B (DISCB) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
26,626.00 | 219,941.87 | 79,119.00 | 41,944.00 | 1,306.00 |
|
Current Assets
|
7,173.00 | 72,958.64 | 26,244.00 | 16,676.00 | 330.00 |
|
Total Assets
|
32,630.00 | 292,900.51 | 105,363.00 | 58,620.00 | 1,636.00 |
|
Total Debt*
|
14,399.00 | 135,472.70 | 30,688.00 | 19,632.00 | 15,711.00 |
|
Net Current Assets
|
3,611.00 | 16,460.10 | 3,650.00 | 7,197.00 | -1,798.00 |
Cashflow ($ Mln)
| Discovery Inc. Series B (DISCB) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
2,798.00 | 29,396.06 | 5,963.00 | 953.00 | 62.00 |
|
Cash Flow from Investing Activities
|
-56.00 | -19,041.68 | -11,058.00 | 2,160.00 | -25.00 |
|
Cash from Financing Activities
|
-853.00 | -13,842.65 | 3,649.00 | 83.00 | 22.00 |
|
Net Cash Inflow / Outflow
|
1,889.00 | -- | -- | -- | 50.00 |
Ratios
Profitability Ratios
| Discovery Inc. Series B (DISCB) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
3.85 | 2.68 | 0.21 | 11.29 | -0.08 |
|
ROE (%)
|
27.04 | 6.59 | 0.41 | 23.16 | -4.43 |
|
ROA (%)
|
3.57 | 2.15 | 0.13 | 8.16 | -0.81 |
|
EBIT Margin (%)
|
18.12 | -- | -- | -- | -- |
|
Net Margin (%)
|
10.15 | 8.19 | 0.30 | 15.89 | -73.41 |
|
Cash Profit Margin (%)
|
0.00 | -- | -- | -- | -- |
Growth Ratios
| Discovery Inc. Series B (DISCB) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
16.49 | 0.05 | 0.41 | 0.13 | 2.17 |
|
EBIT Growth (%)
|
15.01 | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
34.62 | 584.33 | -96.50 | 87.57 | 83.33 |
|
EPS Growth (%)
|
36.16 | 5.79 | -0.97 | 0.76 | 0.81 |
|
Book Value Growth (%)
|
11.00 | -- | -- | -- | -- |
Valuation Ratios
| Discovery Inc. Series B (DISCB) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
19.64 | 0.87 | 804.58 | -- | -112.96 |
|
Price / Book Value
|
1.70 | 0.06 | 2.29 | -- | 4.96 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
4.40 | 3.49 | 22.37 | -- | 176.68 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Discovery Inc. Series B (DISCB) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
1.14 | 1.41 | 0.78 | 0.85 | 53.08 |
|
Short term debt to equity ratio
|
0.07 | 0.06 | 0.05 | 0.01 | 0.04 |
|
Current Ratio
|
2.01 | 1.29 | 1.16 | 1.76 | 2.43 |
|
Quick Ratio
|
2.01 | 1.25 | 0.76 | 1.60 | -- |
|
Interest Coverage
|
3.91 | 1.27 | 0.79 | 6.28 | 0.86 |
Operating Efficiency Ratios
| Discovery Inc. Series B (DISCB) | Grupo Televisa S.A. - ADR | AstraZeneca - ADR | Paramount Skydance Corp Class B | Liberty Media Corp Braves C (BATRK) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
19.32 | 44.04 | 21.73 | 24.43 | 7.10 |
|
Asset Turnover
|
0.34 | 0.26 | 0.43 | 0.51 | 0.35 |
|
Receivable days
|
74.65 | 147.61 | 67.27 | 89.45 | 22.68 |
|
Inventory Days
|
1,496.02 | 15.09 | 190.99 | 32.84 | -- |
|
Payable days
|
31.98 | 178.33 | 75.98 | 25.30 | 57.75 |
|
Cash Conversion Cycle
|
1,538.69 | -15.63 | 182.29 | 96.99 | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
